http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1305703-C
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 |
| filingDate | 1987-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71d04c467362f44a1f834eb45a140f0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a95d3a0165ca3595187408a4ed2f43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d97e28336e182007716d2a1a64603d0 |
| publicationDate | 1992-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1305703-C |
| titleOfInvention | 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo-[1,5-a] pyrimidines |
| abstract | 30,163 4,5-DIHYDRO AND 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]-PYRIMIDINES ABSTRACT OF THE INVENTION Novel compounds having tbe following structural formula: Ia or Ib wherein --- may represent the presence of a double bond between the C6 and C7 position, Ia, or the absence of a double bond between the C6 and C7 position, Ib; R1 is selected from the group consisting essentially of hydrogen, bromo, chloro, carbamoyl, carboxyl, carboxyalkoxyl where alkoxyl is (C1-C3), cyano, -CO-CF3, COONa, , -CO-C(CH3)3, and where X is hydrogen, cyano, halogen and nitro; R2, R4 and R5 may be hydrogen and lower alkyl(C1-C3); R3 is hydrogen, alkyl(C1-C3), where R7 and R8 may be the same or different and are selected from the group consisting essentially of hydrogen, halogen, alkyl(C1-C3), nitro, alkoxy(C1-C3), trifluoro-methyl, acetylamino or N-alkylacetylamino where alkyl is (C1-C3), and R3 may also be selected from a monovalent radical selected from the class consisting essentially of 3-thienyl, 2-pyridinyl, 3-pyridinyl and 4-pyridinyl, either of said pyridinyl radicals being optionally substituted with an alkyl radical R9, where alkyl is (C1-C4), and the structures of the monovalent 2-pyridinyl, 3-pyridinyl and 4-pyridinyl moieties are depicted respectively as: and ; R6 is hydrogen or alkyl-(C1-C3); pharmaceutical compositions of matter containing the above-defined compounds; methods for using the com-pounds as anxiolytic agents, antihypertensive agents or antidepressant agent in mammals; processes for the preparation of the compounds. |
| priorityDate | 1986-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.